Most “rapid detection Point of Care” drug test devices/kits utilise a technology called lateral flow. Sometimes called a “rapid test” which is based upon the principle of competitive inhibition binding. Therefore, drugs that may be present in the urine / oral fluid specimen compete against their respective drug conjugate for binding sites on their specific antibody. During testing a portion of the urine / oral fluid specimen migrates upward through a membrane strip by capillary action (also known as “wicking”). Based upon the presence or absence of a drug then a line will be visible or not in the “test” area (“T” line). The control line (“C” line) will be visible when the test strip has run correctly. All ITS “Point of Care” drug test devices/kits come with clear instructions for use and the support of a friendly and highly experienced team of industry professionals.
Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?
Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018.The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.
Official figures show that drug deaths have risen sharply in England and Wales, reaching record numbers last year. A total of 4,359 people died due to drug poisoning last year, this includes accidental overdoses and suicides from medicinal drugs, as well as illicit drug use.